Analystreport

PTC Therapeutics, Inc. (NASDAQ: PTCT) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.

PTC Therapeutics, Inc.  (PTCT) 
Last ptc therapeutics, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.ptcbio.com